• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在临床试验环境中,日本版国际不宁腿综合征研究组评定量表评估不宁腿综合征的可靠性、有效性和反应度。

Reliability, validity, and responsiveness of the Japanese version of International Restless Legs Syndrome Study Group rating scale for restless legs syndrome in a clinical trial setting.

机构信息

Japan Somnology Center, Neuropsychiatric Research Institute, Japan; Department of Somnology, Tokyo Medical University, Japan.

出版信息

Psychiatry Clin Neurosci. 2013 Sep;67(6):412-9. doi: 10.1111/pcn.12074. Epub 2013 Aug 5.

DOI:10.1111/pcn.12074
PMID:23910574
Abstract

AIM

This study was conducted to verify the reliability, validity, and responsiveness of the Japanese version of the International Restless Legs Syndrome Study Group Rating Scale for restless legs syndrome (J-IRLS) as a sub-study of a clinical trial of pramipexole against restless legs syndrome.

METHODS

After evaluating the test-retest reliability, concurrent validity and construct validity were analyzed. The responsiveness of J-IRLS was confirmed by evaluating the correlations between the changes in J-IRLS total score after treatment, Clinical Global Impression Improvement Scale (CGI-I), and Patient Global Impression.

RESULTS

Test-retest reliability of J-IRLS was good (intra-class correlation coefficient, 0.877; 95% confidence interval, 0.802-0.925). The correlation coefficient of J-IRLS total score and CGI-S score for the first and second visit was 0.804 and 0.796, respectively (both P < 0.0001). Factor analysis of J-IRLS itemsalone identified a two-factor structure. Exploratory analysis on 10 items of J-IRLS together with the Japanese version of the Pittsburgh Sleep Quality Index revealed that several items on the Japanese version of the Pittsburgh Sleep Quality Index appeared as the third factor. The correlations of CGI-I and Patient Global Impression with change in J-IRLS total score after treatment were highly significant.

CONCLUSIONS

Reliability, validity, and responsiveness of J-IRLS were considered adequate. The scale is highly applicable both for evaluating the severity of restless legs syndrome and for assessing drug efficacy.

摘要

目的

本研究旨在验证中文版国际不宁腿综合征研究组评定量表(J-IRLS)用于评估普拉克索治疗不宁腿综合征的临床试验的可靠性、有效性和反应度,这是该临床试验的一个子研究。

方法

在评估了测试-重测信度后,分析了同时效度和结构效度。通过评估治疗后 J-IRLS 总分的变化与临床总体印象改善量表(CGI-I)和患者总体印象之间的相关性,确认了 J-IRLS 的反应度。

结果

J-IRLS 的测试-重测信度良好(组内相关系数为 0.877;95%置信区间为 0.802-0.925)。J-IRLS 总分和 CGI-S 评分的首次和第二次就诊的相关系数分别为 0.804 和 0.796(均 P < 0.0001)。对 J-IRLS 项目进行因子分析单独确定了一个两因素结构。对 J-IRLS 的 10 个项目与日本版匹兹堡睡眠质量指数(PSQI)一起进行的探索性分析表明,日本版 PSQI 的几个项目出现为第三个因素。CGI-I 和患者总体印象与治疗后 J-IRLS 总分变化的相关性具有高度显著性。

结论

J-IRLS 的可靠性、有效性和反应度被认为是充分的。该量表既适用于评估不宁腿综合征的严重程度,也适用于评估药物疗效。

相似文献

1
Reliability, validity, and responsiveness of the Japanese version of International Restless Legs Syndrome Study Group rating scale for restless legs syndrome in a clinical trial setting.在临床试验环境中,日本版国际不宁腿综合征研究组评定量表评估不宁腿综合征的可靠性、有效性和反应度。
Psychiatry Clin Neurosci. 2013 Sep;67(6):412-9. doi: 10.1111/pcn.12074. Epub 2013 Aug 5.
2
The reliability, validity and responsiveness of the International Restless Legs Syndrome Study Group rating scale and subscales in a clinical-trial setting.国际不宁腿综合征研究组评定量表及分量表在临床试验环境中的信度、效度和反应度
Sleep Med. 2006 Jun;7(4):340-9. doi: 10.1016/j.sleep.2005.12.011. Epub 2006 May 19.
3
Long-term open-label study of pramipexole in patients with primary restless legs syndrome.原发性不安腿综合征患者普拉克索的长期开放性研究。
J Neurol Sci. 2010 Jul 15;294(1-2):62-6. doi: 10.1016/j.jns.2010.04.003. Epub 2010 May 7.
4
Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study.普拉克索治疗日本原发性不安腿综合征患者的疗效和安全性:一项多导睡眠图随机、双盲、安慰剂对照研究。
Sleep Med. 2010 Jan;11(1):11-6. doi: 10.1016/j.sleep.2009.03.009. Epub 2009 Dec 4.
5
Relation of the International Restless Legs Syndrome Study Group rating scale with the Clinical Global Impression severity scale, the restless legs syndrome 6-item questionnaire, and the restless legs syndrome-quality of life questionnaire.国际不宁腿综合征研究组评分量表与临床总体印象严重程度量表、不安腿综合征 6 项问卷和不安腿综合征生活质量问卷的关系。
Sleep Med. 2013 Dec;14(12):1375-80. doi: 10.1016/j.sleep.2013.09.008. Epub 2013 Oct 18.
6
Ropinirole in patients with restless legs syndrome and baseline IRLS total scores ≥ 24: efficacy and tolerability in a 26-week, double-blind, parallel-group, placebo-controlled study followed by a 40-week open-label extension.罗匹尼罗治疗基线 IRLS 总分≥24 的不安腿综合征患者:26 周双盲、平行分组、安慰剂对照研究及随后 40 周开放性扩展研究的疗效和耐受性。
Clin Ther. 2013 Sep;35(9):1321-36. doi: 10.1016/j.clinthera.2013.06.016. Epub 2013 Aug 9.
7
The reliability, validity and responsiveness of the Restless Legs Syndrome Quality of Life questionnaire (RLSQoL) in a trial population.不安腿综合征生活质量问卷(RLSQoL)在试验人群中的信度、效度及反应度。
Health Qual Life Outcomes. 2005 Dec 5;3:79. doi: 10.1186/1477-7525-3-79.
8
Efficacy and safety of pramipexole in chinese patients with restless legs syndrome: results from a multi-center, randomized, double-blind, placebo-controlled trial.普拉克索治疗中国不安腿综合征患者的疗效和安全性:一项多中心、随机、双盲、安慰剂对照试验的结果。
Sleep Med. 2012 Jan;13(1):58-63. doi: 10.1016/j.sleep.2011.03.021. Epub 2011 Dec 3.
9
Clinical efficacy of ropinirole for restless legs syndrome is not affected by age at symptom onset.罗匹尼罗治疗不宁腿综合征的临床疗效不受症状起始年龄的影响。
Sleep Med. 2008 Dec;9(8):899-902. doi: 10.1016/j.sleep.2007.08.017. Epub 2007 Nov 19.
10
Post Hoc Analysis of Data from Two Clinical Trials Evaluating the Minimal Clinically Important Change in International Restless Legs Syndrome Sum Score in Patients with Restless Legs Syndrome (Willis-Ekbom Disease).两项评估不宁腿综合征(Willis-Ekbom病)患者国际不宁腿综合征总评分最小临床重要变化的临床试验数据的事后分析。
J Clin Sleep Med. 2016 Jan;12(1):63-70. doi: 10.5664/jcsm.5396.

引用本文的文献

1
Validation of the Lithuanian Version of the International Restless Legs Syndrome Study Group Rating Scale for Restless Legs Syndrome.立陶宛版国际不宁腿综合征研究组不宁腿综合征评定量表的验证
Medicina (Kaunas). 2025 May 31;61(6):1028. doi: 10.3390/medicina61061028.
2
Efficacy of a Personalized Mobile Health Intervention (BedTime) to Increase Sleep Duration Among Short-Sleeping Patients With Type 2 Diabetes: Protocol for a Pilot Randomized Controlled Trial.个性化移动健康干预措施(BedTime)对增加2型糖尿病短睡眠患者睡眠时间的疗效:一项试点随机对照试验方案
JMIR Res Protoc. 2025 Apr 14;14:e64023. doi: 10.2196/64023.
3
Review of Severity Rating Scales for Restless Legs Syndrome: Critique and Recommendations.
不宁腿综合征严重程度评分量表综述:批判与建议
Mov Disord Clin Pract. 2014 Sep 30;1(4):317-324. doi: 10.1002/mdc3.12088. eCollection 2014 Dec.
4
Restless legs syndrome augmentation among Japanese patients receiving pramipexole therapy: Rate and risk factors in a retrospective study.接受普拉克索治疗的日本患者中不安腿综合征症状加重情况:一项回顾性研究中的发生率及危险因素
PLoS One. 2017 Mar 6;12(3):e0173535. doi: 10.1371/journal.pone.0173535. eCollection 2017.